| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Indian pharmaceutical companies are grabbing headlines on an almost daily
basis and are increasingly carving out market shares for themselves in the US
and many other markets around the world. Several leading Indian pharmaceutical
companies have applied themselves to the challenge of entering Western markets
with great success. These companies now present a very serious threat to the
existing Western generic companies in their domestic markets as they take
ever-larger market shares and increase the levels of competition.
Why has this challenge arisen - what advantages do Indian companies enjoy that
enable them to compete so successfully with Western generic companies?
It is the purpose of this report to answer that question and to provide
Western pharmaceutical companies and others that are interested by this
phenomenon with some explanation of the background. It will also offer some
guidance as to how companies might deal with what some see as a threat and
others view as a welcome source of low-cost generics.
Report Highlights and Key Findings
- Provides a unique analysis of the leading Indian companies and their areas
of expertise
- Examines the factors that have led to their success
- Overview of Indian R&D efforts directed towards developing new New
Chemical Entities
- Investigates the local Indian market environment
- Provides a detailed legislative background and role of government agencies
in the Indian generics industry
- Analysis of current and predicted future market sizes
- Identifies the drivers of future market growth
- Looks at current and past multinational companies present in India
- Comprehensively explains local healthcare insurance systems
- Explains why Indian generics companies have been so successful
- Identifies the market leaders in the domestic market
- Explores growth strategies companies use on their way up
- Identifies when the Indian growth spurt started
- Investigates the current status of intellectual property in India
- Elucidates the opportunities in the domestic market for foreign companies
- Provides a unique assessment of the Indian generics market both currently
and prospectively
- Identifies which companies are likely to be the future generic giants
- Provides insight into what Indian companies themselves see as their main
competitors
- Suggests the direction that the Indian pharmaceutical industry likely to
follow in the future
Features of This Report:
- Research and analysis by an expert with inside knowledge of an Indian
generic company
- Provides an crucial explanation of the key elements in the growing Indian
success
- Tabulates and evaluates the leading players in the Indian domestic market
- Discusses the history and future prospects of the market leaders
- Analyses the current and projected market sizes
- Includes an examination of major trends in India and their probable impact
- Provides an overview of population and social trends that will affect
growth
- Offers and in-depth analysis of the IP situation and how it has changed
and is likely to change in the future
Reasons to Buy This Report:
- To establish if Indian generics businesses are taking a greater share in
the European and US generic markets;
- Determines the impact of Indian generics on European and US generic
competitors;
- Provides an analysis of the importance of Indian API manufacturers to US
markets;
- Establishes the current situation of Indian manufacturing;
- Importantly surveys the trends in India that are likely to impact Western
markets.
TABLE OF CONTENTS
- Contents List
- List of Tables
- List of Figures
- Executive Summary
1. INTRODUCTION TO THE INDIAN PHARMACEUTICAL INDUSTRY
- 1.0 A Brief History
- 1.1 The First Companies
- 1.2 Government Measures to Encourage the Industry
- 1.2.1 Patents
- 1.2.2 Price Controls
- 1.2.3 Government Incentives
- 1.3 Leading Companies
- 1.3.1 The Top Ten Indian Pharmaceutical Companies in 2007
- 1.4 Changes in National Pharmaceutical Export-Import Ratios
- 1.4.1 The Shift from Active Pharmaceutical Ingredients to Formulations
- 1.5 The Medium-to-Small Players
- 1.6 Overseas Presence in the Indian Market
- 1.6.1 Multinational Branded Companies
- 1.6.2 Generic Companies
2. GROWTH OF THE INDIAN GENERICS INDUSTRY
- 2.0 History of the Indian Generics Industry
- 2.1 Origins - How did it all Start?
- 2.1.1 The Ladder to Success
- 2.2 Reverse Engineering
- 2.3 Speed to Market
- 2.4 Branded Generics - The Indian Way
- 2.5 Growth Strategies and Drivers
- 2.5.1 Active Pharmaceutical Ingredients
- 2.5.2 Contract Manufacture of Formulations
- 2.5.3 Own Registrations Abroad
- 2.5.4 Patent Challenges
- 2.5.5 Subsidiaries/Joint-Ventures
- 2.5.6 Acquisitions - The Rationale
- 2.5.6.1 Recent Acquisitions
3. INDIAN DRUG LEGISLATION
- 3.0 Legislative Background
- 3.1 The Drugs and Cosmetics Act, 1940
- 3.2 Drug Policy of 1986
- 3.3 Liberalisation Since 1991
- 3.4 Pharmaceutical Registration
- 3.5 Data Exclusivity
- 3.6 Barriers to Foreign Ownership
- 3.7 Price Controls
- 3.8 Patents and Intellectual Property
- 3.8.1 Indian Patents Third Amendment Bill, 2005
- 3.8.2 Trade-Related Intellectual Property Rights (TRIPS)
- 3.8.3 Doha Declaration
- 3.8.4 Impact on International Relations
- 3.9 Export Incentives
4. THE INDIAN DRUG MARKET
- 4.0 Domestic Market and Healthcare System
- 4.1 Market Size and Drivers of Growth
- 4.1.1 Market Size
- 4.1.2 Growth Drivers
- 4.1.2.1 Increased Prosperity and Life Expectancy
- 4.1.2.2 Improving Transport
- 4.1.2.3 Healthcare Expenditure
- 4.2 Leading Domestic Companies
- 4.3 Leading Foreign Players
- 4.4 The Indian Market in an International Context
- 4.5 Market Growth - Past and Future
- 4.6 The Healthcare System
- 4.6.1 Basic Healthcare
- 4.6.2 Hospitals
- 4.6.3 Health Insurance
- 4.6.3.1 Social Health Insurance
- 4.6.3.2 Private Health Insurance
- 4.6.4 The Poor
- 4.7 Traditional, Herbal and Ayurvedic Medicines
- 4.8 Factors Influencing Pricing
5. COMPANY PROFILES
- 5.1 [Company]
- 5.1.1 History
- 5.1.2 Sales Growth
- 5.1.3 Major Products
- 5.1.4 Overseas Presence
- 5.1.4.1 United States
- 5.1.4.2 Europe
- 5.2 [Company]
- 5.2.1 History
- 5.2.2 Sales Growth
- 5.2.3 Major Products
- 5.2.4 Overseas Presence
- 5.3 [Company]
- 5.3.1 History
- 5.3.2 Sales Growth
- 5.3.3 Major Products
- 5.3.4 Overseas Presence
- 5.4 [Company]
- 5.4.1 History
- 5.4.2 Sales Growth
- 5.4.3 Major Products
- 5.4.4 Overseas Presence
- 5.5 [Company]
- 5.5.1 History
- 5.5.2 Sales Growth
- 5.5.3 Major Products
- 5.5.4 Overseas Presence
- 5.6 [Company]
- 5.6.1 History
- 5.6.2 Sales Growth
- 5.6.3 Major Products
- 5.6.4 Overseas Presence
- 5.7 [Company]
- 5.7.1 History
- 5.7.2 Sales Growth
- 5.7.3 Major Products
- 5.7.4 Overseas Presence
- 5.8 [Company]
- 5.8.1 History
- 5.8.2 Sales Growth
- 5.8.3 Major Products
- 5.8.4 Overseas Presence
- 5.9 [Company]
- 5.9.1 History
- 5.9.2 Sales Growth
- 5.9.3 Major Products
- 5.9.4 Overseas Presence
- 5.10 [Company]
- 5.10.1 History
- 5.10.2 Sales Growth
- 5.10.3 Major Products
- 5.10.4 Overseas Presence
6. OUTLOOK FOR THE INDIAN GENERICS INDUSTRY
- 6.1 Growth Opportunities and Possible Threats for Indian Companies
- 6.1.1 Opportunities
- 6.1.3 Acquisitions
- 6.2 Threats
- 6.2.1 Market Saturation and Consolidation
- 6.2.2 Competition
- 6.3 Research and Development
- 6.3.1 New Developments
- 6.3.2 Alliances
7. CONCLUSIONS AND INSIGHTS FOR THE INDIAN GENERICS MARKET
- 7.1 Is India the Pharmaceutical Giant of the Future?
- 7.1.1 Domestic Market
- 7.1.2 International Growth
- 7.1.3 Environmental Concerns
- 7.1.4 Growth through Consolidation
- 7.1.5 Growth through New Products
- 7.1.5.1 Generics
- 7.1.5.2 New Chemical Entities
- 7.2 Are Indian Companies Allies or Opponents?
- 7.2.1 Alliances
- 7.2.2 Indian Companies as Competitors
- 7.3 Who will be Tomorrow's Generic Champions?
List of Tables
- Table 1 Presence of Asian Pharmaceutical Companies at Annual Global
Exhibitions, 1997-2005
- Table 1.1 Pricing Differentials of Ciprofloxacin (10
|
